BP000159-CYT-350: Recombinant Mouse Interleukin-6 (IL-6) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of IL-6-dependent murine 7TD1 cells is < 0.02 ug/ml, corresponding to a specific activity of > 50,000,000 units/mg.
Purity: > 96% by SDS-PAGE and RP-HPLC.BP000159-CYT-388: Recombinant Rat Interleukin-6 (IL-6) Protein
Source: E. coli-derived.
The ED50 = 0.03-0.1 ug/ml corresponding to a specific activity of 10-34 MIU/mg. The biological activity is determined by measuring the dose-dependant proliferation of IL-6 dapendent B9 cells. A concentration range of 0.1 to 10.0 ug/ml is effective for most in vitro applications.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000158-CYT-212: Recombinant Human IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be < 0.15 ug/ml, corresponding to a Specific Activity of 6.7 MIU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000158-CYT-387: Recombinant Rat IL-5
Source: E. coli-derived.
The ED50 range=0.3-1.0 ug/ml as determined by the dose-dependant stimulation of the proliferation of BCL-1 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000158-CYT-689: Recombinant Mouse IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be 1.7 ug/ml, corresponding to a specific activity of 588,235.3 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000157-CYT-271: Recombinant Human Interleukin-4 (IL-4) Protein, CHO
Source: Chinese Hamster Ovarian Cells-derived.
Measured in a cell proliferation assay using TF-1 cells. The ED50 for this effect is 0.05-0.2 ug/ml corresponding to a Specific Activity of 5-20 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000157-CYT-282: Recombinant Mouse Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant induction of HT-2 cell proliferation is less than 2 ug/ml corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 96% by SDS-PAGE and RP-HPLC.BP000157-CYT-385: Recombinant Rat Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
Determined by its ability to suppress LPS-induced TNF-alpha and MIP-2 production in mouse splenocytes.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000157-CYT-483: Recombinant Human Interleukin-4 (IL-4) Protein, His Tag
Source: E. coli-derived.
The ED50 for this effect is <1.8 ug/ml. Measured in a cell proliferation assay using TF1 human erythroleukemic cells.
Purity: > 95% by SDS-PAGE.BP000157-CYT-211: Recombinant Human Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.2 ug/ml, corresponding to a Specific Activity of 5,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.